Viking Therapeutics, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for VKTX, updated each market day.
VKTX AI Sentiment
AI predicts Viking Therapeutics, Inc stock is likely to increase over the next 10 market days.
Prediction date: Aug. 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Viking Therapeutics, Inc
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Sector
Exchange
Market Cap
$3,884,542,802
Cap Tier
Employees
59
Headquarters
SAN DIEGO, CA
Listed Since
April 29, 2015
VKTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VKTX Volatility
Viking Therapeutics, Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
